跳至主要内容
临床试验/NCT02907554
NCT02907554已完成4 期

Effects of Cyclosporine A Pretreatment of Deceased Donor on Kidney Graft Function: A Randomized Controlled Trial

University Hospital, Clermont-Ferrand2 个研究点 分布在 1 个国家目标入组 648 人开始时间: 2017年12月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
648
试验地点
2
主要终点
Percentage of delayed graft function defined by a need of at least one hemodialysis session

研究概览

简要总结

Organ donors included in the study are randomized to a control group or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. Harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. According to the pretreatment of the transplant, delayed graft function during the first week was evaluated as well as kidney function at different timepoints and mortality during the first year after transplantation.

详细描述

Organ donors included in the study are randomized to a control group receiving a placebo or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. In the operating theater organs are harvested. Thereafter, harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. The management of transplanted patients is performed as usual. According to the pretreatment of the transplant, delayed graft function during the first week (need of at least one dialysis session) was evaluated as well as kidney function at different timepoints (slow graft function, estimated creatinine clearance on day 3 and 7, acute and chronic graft rejection), length of hospital stay and mortality during the first year after transplantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For organ donors:
  • Male and females aged 18 to 80 years
  • Brain death
  • Inclusion criteria for organ recipients:
  • Male and females aged 18 to 80 years
  • Indication of kidney transplantation
  • Informed consent

排除标准

  • For organ donors:
  • Contra-indication for multiorgan procurement (infections, cancer, etc)
  • Preexistent chronic renal failure.
  • Refusal for organ procurement by the donor (confirmed by the French national register or reported by the next-of-kin).
  • Exclusion criteria for organ recipients:
  • Need for a double kidney transplantation.
  • Need for a multiorgan transplantation

研究组 & 干预措施

intervention group

Experimental

the intervention group receives 2.5 mg/kg of cyclosporine

干预措施: cyclosporine A (Drug)

control group

Placebo Comparator

control group receives a placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Percentage of delayed graft function defined by a need of at least one hemodialysis session

时间窗: within the 7 days following renal transplantation.

次要结局

  • Percentage of acute and chronic graft rejection(during the first year after transplantation)
  • Mortality(during the first year after transplantation)
  • Postoperative evolution of estimated creatinine clearance(at day 3 and 7)
  • Percentage of slow graft function defined by a urine output < 1000 ml(at on 1 day after transplantation)
  • Percentage of slow graft function defined by a decrease in plasma creatinine concentration of less than 30% or 70%(at day 3 and 7 after transplantation)
  • Percentage of primary graft dysfunction(during the first year after transplantation)
  • hospital length of stay(at day 1)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Cyclosporine A Pretreatment and Kidney Graft Function | 临床试验